875. Indirect Treatment Comparison of 48-Week Efficacy and Safety of Cabotegravir + Rilpivirine Long-Acting Every 2 Months to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Sup...

por Snedecor, Sonya J, Schroeder, Melanie, Van de Velde, Nicolas
Publicado 2021

Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

por Delgleize, Emmanuelle, Leeuwenkamp, Oscar, Theodorou, Eleni, Van de Velde, Nicolas
Publicado 2016

Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in...

por Chounta, Vasiliki, Snedecor, Sonya J., Wu, Sterling, Van de Velde, Nicolas
Publicado 2022

Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV

por Matza, Louis S., Howell, Timothy A., Chounta, Vasiliki, van de Velde, Nicolas
Publicado 2022

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries

por Sauboin, Christophe, Van Bellinghen, Laure-Anne, Van De Velde, Nicolas, Van Vlaenderen, Ilse
Publicado 2019

Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?

por Drolet, Mélanie, Boily, Marie-Claude, Van de Velde, Nicolas, Franco, Eduardo L., Brisson, Marc
Publicado 2013

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study

por Sauboin, Christophe J., Van Bellinghen, Laure-Anne, Van De Velde, Nicolas, Van Vlaenderen, Ilse
Publicado 2015

1017. Haves vs. Have-Nots in Healthcare Communication: Examining the Paradox Where PLHIV Who Need Quality Discussions with their Providers the Most, Access it the Least

por Rios, Patricia De Los, Young, Benjamin, Muchenje, Marvelous, Van de Velde, Nicolas, Okoli, Chinyere
Publicado 2020

2496. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Daily Oral and Long-Acting Injectable Antiretroviral Treatment among People Living with HIV

por Matza, Louis S, Paulus, Trena, Garris, Cindy, Van de Velde, Nicolas, Chounta, Vasiliki, Deger, Kristen A
Publicado 2019

1635. Assessing the Potential Reduction in Morbidity and Mortality Attainable by Delayed Influenza Vaccine Strain Selection

por Kissler, Stephen M, Joshi, Keya, Van de Velde, Nicolas, Vicic, Nevena, Park, Yoonyoung, Rudin, Deborah, Ghaswalla, Parinaz
Publicado 2023

Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV

por Matza, Louis S., Paulus, Trena M., Garris, Cindy P., Van de Velde, Nicolas, Chounta, Vasiliki, Deger, Kristen A.
Publicado 2020

76. Effects of the “Undetectable = Untransmittable” (“U=U”) Educational Campaign on Treatment Outcomes and Perceptions among People Living with HIV in North American Countries...

por Spinelli, Frank, Richman, Bruce, Rios, Patricia De Los, Young, Benjamin, Muchenje, Marvelous, Van de Velde, Nicolas, Okoli, Chinyere
Publicado 2021

1018. Health Technology Assessment of New Long-Acting, Directly-Observed HIV Treatments in Canada: Impact of Real-World Adherence to Daily Oral Therapy on Treatment, Transmission a...

por Arthurs, Erin, Parker, Ben, Jacob, Ian, Becker, Debbie, Lee, Amy, Hayward, Olivia, Chounta, Vasiliki, Anderson, Sarah-Jane, Van de Velde, Nicolas
Publicado 2020

Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling stu...

por Parker, Ben, Ward, Tom, Hayward, Olivia, Jacob, Ian, Arthurs, Erin, Becker, Debbie, Anderson, Sarah-Jane, Chounta, Vasiliki, Van de Velde, Nicolas
Publicado 2021

Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic

por Roberts-McCarthy, Erin, Buck, Philip O., Smith-Ray, Renae L., Van de Velde, Nicolas, Singh, Tanya, Mansi, James, Shah, Amy, Taitel, Michael
Publicado 2023

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

por Wang, Xuan, Haeussler, Katrin, Spellman, Anne, Phillips, Leslie E., Ramiller, Allison, Bausch-Jurken, Mary T., Sharma, Pawana, Krivelyova, Anna, Vats, Sonam, Van de Velde, Nicolas
Publicado 2023

Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe

por Akinwunmi, Babatunde, Buchenberger, Daniel, Scherzer, Jenny, Bode, Martina, Rizzini, Paolo, Vecchio, Fabio, Roustand, Laetitia, Nachbaur, Gaelle, Finkielsztejn, Laurent, Chounta, Vasiliki, Van de Velde, Nicolas
Publicado 2021

2359. Relative effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines in adults at higher risk for severe COVID-19 outcomes

por Nguyen, Van Hung, Boileau, Catherine, Bogdanov, Alina, Zeng, Ni, Bonafede, Mac, Ducruet, Thierry, Rosen, Andrew M, Martin, David, Esposito, Daina, Van de Velde, Nicolas, Kopel, Hagit, Mansi, James
Publicado 2023

Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV

por Okoli, Chinyere, Brough, Garry, Allan, Brent, Castellanos, Erika, Young, Benjamin, Eremin, Anton, Corbelli, Giulio Maria, Mc Britton, Marta, Muchenje, Marvelous, Van de Velde, Nicolas, de los Rios, Patricia
Publicado 2020

1045. Treatment-Related Physical, Emotional, and Psychosocial Challenges and their Impact on Indicators of Quality of Life

por Rios, Patricia De Los, Allan, Brent, Okoli, Chinyere, Young, Benjamin, Castellanos, Erika, Brough, Garry, Eremin, Anton, Corbelli, Giulio Maria, Muchenje, Marvelous, Britton, Marta M C, Van de Velde, Nicolas
Publicado 2020